|
CEL-SCI Corporation Announces Closing of Public Offering for Gross Proceeds …
PharmiWeb.com (press release) CEL-SCI Corporation (NYSE MKT: CVM) a late-stage oncology company today announced that it has closed an underwritten public offering of 7894737 shares of common stock and 1973684 warrants to purchase shares of common stock. For every four … |
